SEC Form 4 · accession 0000899243-18-021022
CareDx, Inc. · CDNA
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Sasha King
Officer — Chief Commercial Officer
Period of report
Aug 1, 2018
Accepted (ET)
Aug 1, 2018 · 7:32 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001217234
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Aug 1, 2018 | M | 3,750 | $1.00 | A | 71,792 | D | |
| Common Stock | Aug 1, 2018 | M | 2,708 | $1.07 | A | 74,500 | D | |
| Common StockF1 | Aug 1, 2018 | S | 9,458 | $14.0341 | D | 65,042 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Employee Stock Option (right to buy)F2 | $1.00 | Aug 1, 2018 | M | 3,750 | D | — | Apr 21, 2027 | Common Stock | 3,750 | 8,250 | D |
| Employee Stock Option (right to buy)F3 | $1.07 | Aug 1, 2018 | M | 2,708 | D | — | Jun 9, 2027 | Common Stock | 2,708 | 7,292 | D |
Explanation of responses
- F1The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $14.00 to $14.15, inclusive. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer or a security holder of the Issuer full information regarding the number of shares purchased or sold at each separate price.
- F225% of the shares subject to the option vested on March 30, 2018 and 1/48th of the shares subject to the option vest monthly thereafter.
- F325% of the shares subject to the option vested on June 9, 2018 and 1/48th of the shares subject to the option vest monthly thereafter.